معرفی
David W. Dowdy, MD, PhD, ScM, serves as Executive Vice Dean for Academic Affairs and Professor at Johns Hopkins Bloomberg School of Public Health with joint appointments at the School of Medicine. He holds primary affiliation with the Department of Epidemiology and joint appointments in the International Health division and Global Disease Epidemiology and Control division. Dr. Dowdy is an infectious disease epidemiologist and general internist focused on tuberculosis, the world's most deadly infectious disease.
Dr. Dowdy earned his MD (2008), PhD (2008), and ScM (2002) from Johns Hopkins University, and BS (1999) from Duke University. His interdisciplinary research integrates experimental and observational epidemiology, infectious disease modeling, health economics, and implementation science. He directs the Bioinformatics, Modeling, and Biostatistics Core of the JHU Tuberculosis Research Advancement Center and serves as PI/MPI of four NIH-funded clinical trials focused on TB case-finding and preventive treatment.
His research spans multiple continents including Malawi, Uganda, South Africa, Vietnam, Pakistan, Ghana, Mozambique, Tanzania, and the United States. Dr. Dowdy's work emphasizes translating epidemiological data into meaningful policy decisions, with particular focus on cost-effectiveness of TB interventions and diagnostic strategies in resource-limited settings. His recent publications (2023-2025) demonstrate continued productivity with emphasis on TB screening approaches, preventive treatment strategies, diagnostic testing, and implementation science.
Notable Awards and Recognitions:
- Strategic & Technical Advisory Group on Tuberculosis (STAG-TB), World Health Organization (2023)
- JHU Catalyst Award recipient (2020)
- Multiple Advising, Mentoring, and Teaching Recognition Awards (2018, 2013)
- Young Investigator Prize, International Union Against Tuberculosis and Lung Disease (2012)
- Teaching Excellence Awards from both Johns Hopkins and UCSF
Dr. Dowdy is deeply committed to mentorship, with many senior-author publications first-authored by his trainees. He actively contributes to major research initiatives including the Uganda Tuberculosis Implementation Research Consortium (U-TIRC), HIV, Infectious Disease and Global Health Implementation Research Institute (HIGH IRI), and the NHLBI-funded HLB-SIMPLe Alliance. His work consistently addresses critical gaps in TB control, particularly around case-finding and diagnosis in high-burden settings.
